A study evaluating drug drug interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients.
Latest Information Update: 28 Dec 2016
At a glance
- Drugs Darunavir (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
Most Recent Events
- 28 Dec 2016 New trial record
- 20 Dec 2016 Results published in the Journal of Antimicrobial Chemotherapy